Triplicate Prescription Program (TPP)

Methylphenidate Prescriptions

Update - May 2010

All methylphenidate products require a TPP prescription unless evidence confirms low potential for abuse or misuse.
In 2007, Concerta® was removed as a TPP methylphenidate product. Evidence to date still supports this exclusion.
- Note: A pharmacist who receives a script for Concerta® written on a regular prescription pad and determines it is appropriate to substitute a generic product must consult with the physician. If the pharmacist and physician agree, the physician will provide a TPP prescription for the generic product.
Introduction of new generic product, Novo-methylphenidate ER C®, has raised questions from pharmacists about TPP requirements.
- Note: This product requires a triplicate prescription.
TPP requirements for all long-acting stimulants, methylphenidate and others, are currently under review.
Physicians and pharmacists will be notified if there are any further changes to the TPP requirements.